Stroke Prevention

[]     Bhatt Deepak L., Fox Keith A., Hacke Werner, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. The New England journal of medicine.  2006;354:1706–1717.

[]     Gorelick Philip B.. Antiplatelet therapy for recurrent stroke prevention: newer perspectives based on (MATCH), (CHARISMA), and (ESPRIT). Journal of the American Society of Hypertension : JASH.  2008;2:3–7.

[]     Davis Stephen M., Donnan Geoffrey A.. Secondary Prevention after Ischemic Stroke or Transient Ischemic Attack N Engl J Med.  2012;366:1914–1922.

[]     Mohr J. P., Thompson J. L., Lazar R. M., et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. The New England journal of medicine.  2001;345:1444–1451.

[]     Amarenco Pierre, Bogousslavsky Julien, Callahan Alfred, et al. High-dose atorvastatin after stroke or transient ischemic attack. The New England journal of medicine.  2006;355:549–559.

[]     Alberts Mark J.. CHARISMA revisited: is the glass half full or just empty?  International journal of stroke.  2008;3:16–19.

[]     Furlan Anthony J., Reisman Mark, Massaro Joseph, et al. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. The New England journal of medicine.  2012;366:991–999.